Sinan Berkman
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 20
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 12
- Uterine Myomas and Treatments 3
-
- Sarcoma Diagnosis and Treatment 4
- Brain Metastases and Treatment 2
-
- Intraperitoneal and Appendiceal Malignancies 6
- Testicular diseases and treatments 3
-
- Chemotherapy-induced organ toxicity mitigation 2
Sinan Berkman
36 papers receiving 443 citations
Peers
Comparison fields: 5 of 53
- Reproductive Medicine 218
- Obstetrics and Gynecology 193
- Complementary and Manual Therapy 21
- Pulmonary and Respiratory Medicine 86
- Transplantation 7
Countries citing papers authored by Sinan Berkman
This map shows the geographic impact of Sinan Berkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinan Berkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinan Berkman more than expected).
Fields of papers citing papers by Sinan Berkman
This network shows the impact of papers produced by Sinan Berkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinan Berkman. The network helps show where Sinan Berkman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sinan Berkman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 5 | |
| 2 | 2016 | 4 | |
| 3 | 2016 | 17 | |
| 4 | 2015 | 0 | |
| 5 | 2013 | 42 | |
| 6 | 2013 | 6 | |
| 7 | 2012 | 3 | |
| 8 | 2012 | 3 | |
| 9 | 2011 | 6 | |
| 10 | 2011 | 41 | |
| 11 | 2011 | 6 | |
| 12 | 2011 | 3 | |
| 13 | Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population. | 2009 | 17 |
| 14 | 2008 | 23 | |
| 15 | 2007 | 22 | |
| 16 | 2005 | 74 | |
| 17 | Value of glutathion-S transferase pi as a prognostic factor in epithelial ovarian carcinoma. | 2005 | 6 |
| 18 | 2004 | 39 | |
| 19 | 2000 | 13 | |
| 20 | Intraperitoneal cisplatin--mitoxantrone in ovarian cancer patients with minimal residual disease. | 1997 | 5 |
About Sinan Berkman
Sinan Berkman is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Complementary and Manual Therapy, having authored 38 papers that have together received 460 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (12 papers), Intraperitoneal and Appendiceal Malignancies (6 papers), Sarcoma Diagnosis and Treatment (4 papers), Testicular diseases and treatments (3 papers), Uterine Myomas and Treatments (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Reproductive Medicine (218 citations), Obstetrics and Gynecology (193 citations) and Complementary and Manual Therapy (21 citations). Sinan Berkman has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Ergin Bengisu, Samet Topuz, Süleyman Engin Akhan, Cem İyibozkurt, Ahmet Cem İyibozkurt, Ekrem Yavuz, Sıtkı Tuzlalı, Erkan Topuz, Pınar Saip and Uzay Görmüş. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, CRANIO®, European Journal of Cancer and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.